CSNK1G3
Basic information
Region (hg38): 5:123512177-123617049
Links
Phenotypes
GenCC
Source:
- Tourette syndrome (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CSNK1G3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 2 | 0 |
Variants in CSNK1G3
This is a list of pathogenic ClinVar variants found in the CSNK1G3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-123545680-A-G | not specified | Uncertain significance (Jan 02, 2024) | ||
5-123545728-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
5-123545797-T-C | not specified | Uncertain significance (May 06, 2024) | ||
5-123553121-A-T | not specified | Uncertain significance (Aug 21, 2023) | ||
5-123573408-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
5-123573438-A-G | not specified | Uncertain significance (Aug 13, 2021) | ||
5-123573501-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
5-123575736-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
5-123575872-T-A | not specified | Uncertain significance (Jun 07, 2024) | ||
5-123575874-C-T | not specified | Uncertain significance (Feb 09, 2022) | ||
5-123588472-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
5-123590472-G-C | not specified | Uncertain significance (Mar 25, 2024) | ||
5-123590505-G-A | not specified | Uncertain significance (Jan 31, 2022) | ||
5-123591335-C-G | not specified | Uncertain significance (Oct 25, 2022) | ||
5-123591374-C-G | not specified | Uncertain significance (Dec 21, 2022) | ||
5-123595128-G-A | CSNK1G3-related disorder | Likely benign (Aug 30, 2019) | ||
5-123604718-A-G | CSNK1G3-related disorder | Benign (Mar 25, 2019) | ||
5-123604720-A-G | CSNK1G3-related disorder | Likely benign (Mar 11, 2019) | ||
5-123604724-G-T | not specified | Uncertain significance (Mar 02, 2023) | ||
5-123604734-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
5-123614349-T-C | not specified | Uncertain significance (Sep 02, 2024) | ||
5-123614378-C-T | CSNK1G3-related disorder | Likely benign (Dec 09, 2019) | ||
5-123614379-A-G | not specified | Uncertain significance (Aug 11, 2024) | ||
5-123614385-C-T | not specified | Uncertain significance (Oct 08, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CSNK1G3 | protein_coding | protein_coding | ENST00000395412 | 13 | 104947 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000526 | 125712 | 0 | 9 | 125721 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.75 | 121 | 241 | 0.502 | 0.0000119 | 2976 |
Missense in Polyphen | 21 | 83.506 | 0.25148 | 1096 | ||
Synonymous | 0.170 | 77 | 78.9 | 0.976 | 0.00000392 | 806 |
Loss of Function | 4.79 | 2 | 30.6 | 0.0655 | 0.00000178 | 369 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000548 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000622 | 0.0000616 |
Middle Eastern | 0.0000548 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling. Regulates fast synaptic transmission mediated by glutamate (By similarity). {ECO:0000250}.;
- Pathway
- Hedgehog signaling pathway - Homo sapiens (human);Hedgehog Signaling Pathway;IL-7 signaling;JAK STAT pathway and regulation;EPO signaling;VEGF;FoxO family signaling;Hedgehog signaling events mediated by Gli proteins;p53 pathway
(Consensus)
Recessive Scores
- pRec
- 0.181
Intolerance Scores
- loftool
- 0.459
- rvis_EVS
- -0.32
- rvis_percentile_EVS
- 31.46
Haploinsufficiency Scores
- pHI
- 0.426
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.693
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Csnk1g3
- Phenotype
- hematopoietic system phenotype; skeleton phenotype; immune system phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- cellular protein modification process;endocytosis;signal transduction;Wnt signaling pathway;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;positive regulation of canonical Wnt signaling pathway
- Cellular component
- nucleus;cytoplasm;plasma membrane
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;ATP binding